Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The fecal microbial population in the irritable bowel syndrome.

Literature DB >> 7121297

The fecal microbial population in the irritable bowel syndrome.

A Balsari, A Ceccarelli, F Dubini, E Fesce, G Poli.

Abstract

The focal microbial flora composition has been studied in patients affected by irritable bowel syndrome. The statistical analysis of the results showed a decrease of coliforms, lactobacilli and, to a lesser extent, bifidobacteria, as compared to control healthy individuals. Hypotheses on the cause of these modifications and their role in the maintenance and severity of the disease are discussed.

Entities: Disease Species

Mesh：

Year: 1982 PMID： 7121297

Source DB: PubMed Journal: Microbiologica ISSN： 0391-5352

Keyword Cloud
Cited

63 in total

Review 1. Gut microbiota and related diseases: clinical features.

Authors: Vincenzo Stanghellini; Giovanni Barbara; Cesare Cremon; Rosanna Cogliandro; Alexandra Antonucci; Veronica Gabusi; Chiara Frisoni; Roberto De Giorgio; Valentina Grasso; Mauro Serra; Roberto Corinaldesi
Journal: Intern Emerg Med Date: 2010-10 Impact factor: 3.397

Review 2. What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors: Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal: World J Gastroenterol Date: 2013-09-07 Impact factor: 5.742

3. A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial.

Authors: Yu-jing Fan; Shu-jie Chen; Ying-cong Yu; Jian-min Si; Bin Liu
Journal: J Zhejiang Univ Sci B Date: 2006-12 Impact factor: 3.066

The fecal microbial population in the irritable bowel syndrome.

Review 1. Gut microbiota and related diseases: clinical features.

Review 2. What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

3. A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial.

Review 4. Do probiotics have a therapeutic role in gastroenterology?

Review 5. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Review 6. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Review 7. Brain-gut microbiome interactions and functional bowel disorders.

8. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.

9. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

10. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome.